Abstract:Hand-foot-and-mouth disease (HFMD) is a viral illness commonly seen in young children under 5 years of age, characterized by typical manifestations such as oral herpes and rashes on the hands and feet. These symptoms typically resolve spontaneously within a few days without complications. Over the past two decades, our understanding of HFMD has greatly improved and it has received significant attention. A variety of research studies, including epidemiological, animal, and in vitro studies, suggest that the disease may be associated with potentially fatal neurological complications. These findings reveal clinical, epidemiological, pathological, and etiological characteristics that are quite different from initial understandings of the illness. It is important to note that HFMD has been linked to severe cardiopulmonary complications, as well as severe neurological sequelae that can be observed during follow-up. At present, there is no specific pharmaceutical intervention for HFMD. An inactivated Enterovirus A71 (EV-A71) vaccine that has been approved by the China Food and Drug Administration (CFDA) has been shown to provide a high level of protection against EV-A71-related HFMD. However, the simultaneous circulation of multiple pathogens and the evolution of the molecular epidemiology of infectious agents make interventions based solely on a single agent comparatively inadequate. Enteroviruses are highly contagious and have a predilection for the nervous system, particularly in child populations, which contributes to the ongoing outbreak. Given the substantial impact of HFMD around the world, this Review synthesizes the current knowledge of the virology, epidemiology, pathogenesis, therapy, sequelae, and vaccine development of HFMD to improve clinical practices and public health efforts.

Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems

Review of hand, foot and mouth disease

Analysis and Pathogenic Diagnosis of the Hand—foot—and—mouth Disease in Cixi During 2010 to 2011

Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015.

Epidemiology of hand, foot and mouth disease and genomic surveillance of coxsackievirus A10 circulating in Zhejiang Province, China during 2017 to 2022

Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease

A review of the recombination events, mechanisms and consequences of Coxsackievirus A6

The Epidemiological Study of Coxsackievirus A6 revealing Hand, Foot and Mouth Disease Epidemic patterns in Guangdong, China.

Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China

Coxsackievirus B: the important agent of hand, foot, and mouth disease

Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6

An emerging and expanding clade accounts for the persistent outbreak of Coxsackievirus A6-associated hand, foot, and mouth disease in China since 2013.

Genetic Characteristics of the P1 Coding Region of Coxsackievirus A16 Associated with Hand, Foot, and Mouth Disease in China.

Circulation of Coxsackievirus A6 in hand-foot-mouth disease in Guangzhou, 2010-2012

Emergence, Circulation, and Spatiotemporal Phylogenetic Analysis of Coxsackievirus A6- and Coxsackievirus A10-Associated Hand, Foot, and Mouth Disease Infections from 2008 to 2012 in Shenzhen, China

Detection of human enterovirus 71 and coxsackievirus A16 in children with hand, foot and mouth disease in China.

Emerging concerns of atypical hand foot and mouth disease caused by recombinant Coxsackievirus A6 variants in Henan, China

VP1 Sequence Determination and Phylogenetic Analysis of Coxsackievirus A16 Strains

Evolutionary Diversity of Coxsackievirus A6 Causing Severe Hand, Foot, and Mouth Disease - China, 2012-2023

Current status of hand-foot-and-mouth disease

Genomic epidemiology of CVA10 in Guangdong, China, 2013–2021